The debate over the optimal mode of revascularization for patients with multivessel coronary disease still continues, but recent trials and registries showed a long-term prognostic advantage for ...

The coronary sinus reducer (CSR) was not mentioned amongst other available therapies, such as coronary revascularization, optimal medical therapy, and lifestyle interventions, for the treatment of ...